Lau, Colleen; Ramsey, Lani; Mills, Laura; Furuya-Kanamori, Luis; Mills, Deborah
Poor compliance with chemoprophylaxis is a major contributing factor to the risk of malaria in travellers. Pre-travel chemoprophylaxis may improve compliance by enabling ‘drug-free holidays’. The standard treatment dose of atovaquone/proguanil (250mg/100mg, 4 tablets/day for 3 days) provides protection against malaria for at least 4 weeks, and could therefore potentially be used for pre-travel chemoprophylaxis. In this study, we assessed the compliance, tolerability, and...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.